跳至主要内容
临床试验/TCTR20201218006
TCTR20201218006招募中2 期

ow-dose amitriptyline in uninvestigated dyspepsia: a pragmatic open-label cluster randomized controlled trial

antikarn Yingrattanasuk0 个研究点目标入组 40 人开始时间: 2020年12月18日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 60 Years(—)
性别
All

入选标准

  • 1. Patients with functional dyspepsia as defined by Rome IV criteria who have not had an endoscopy (uninvestigated dyspepsia).
  • 2. No history of taking the following drugs for at least 1 week: proton pump inhibitor, antacid, H2antagonist, prokinetic, antispasmodic, carminative.

排除标准

  • 1. Have a history of hypersensitivity to Amitriptyline and / PPIs, or have a history of pregnancy or breastfeeding.
  • 2. Have gastric malignancy, cardiac arrhythmia, congestive heart failure, untreated glaucoma, benign prostate hypertrophy, uncontrolled diabetes.
  • 3. Have a history of using drug groups Antidepressant, Benzodiazepine, NSAIDs including fluoxetine, citalopram, fluvoxamine, sertraline, escitalopram, paroxetine, nortriptyline, mirtazapine, trazodon, chlordiazepoxide, clonazepam, clorazepate, clobazam, diazepam, flurazepam, lorazepam, midazolam, prazepam,triazolam, ibuprofen, naproxen, diclofenac, mefenamic acid, indomethacin and aspirin.

研究者

发起方
antikarn Yingrattanasuk

相似试验